Market Overview

Why BioNTech's Stock Is Trading Higher Today

Why BioNTech's Stock Is Trading Higher Today

BioNTech (NASDAQ: BNTX) shares are trading higher on Tuesday amid continued vaccine optimism. Analysts at BofA also upgraded the stock to Buy and raised their price target from $71 to $105.

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators.

BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab and does not yet have any commercialized medicines.

BioNTech shares were trading up 5.76% at $93.28 on Tuesday. The stock has a 52-week high of $105 and low of $12.52.

Latest Ratings for BNTX

Aug 2020SVB LeerinkMaintainsMarket Perform
Aug 2020SVB LeerinkMaintainsMarket Perform
Jul 2020Canaccord GenuityMaintainsBuy

View More Analyst Ratings for BNTX
View the Latest Analyst Ratings


Related Articles (BNTX)

View Comments and Join the Discussion!

Posted-In: why it's movingUpgrades Analyst Ratings

Latest Ratings

JBLRBC CapitalMaintains38.0
COSTRBC CapitalMaintains412.0
COSTMKM PartnersMaintains325.0
MTNTruist SecuritiesMaintains243.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at